Basic Information | Post buying leads | Suppliers | Cas Database |
Name |
Sodium myristyl sulfate |
EINECS | 214-737-2 |
CAS No. | 1191-50-0 | Density | N/A |
PSA | 74.81000 | LogP | 5.24510 |
Solubility | Soluble in water. | Melting Point |
190 - 192 C |
Formula | C14H30 O4 S . Na | Boiling Point | N/A |
Molecular Weight | 316.438 | Flash Point | N/A |
Transport Information | N/A | Appearance | white solid |
Safety | Poison by intraperitoneal and intravenous routes. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of SOx and Na2O. See also SULFATES. | Risk Codes | 36/37/38 |
Molecular Structure | Hazard Symbols | Xi | |
Synonyms |
1-Tetradecanol,hydrogen sulfate sodium salt (8CI);1-Tetradecanol, hydrogen sulfate, sodiumsalt (9CI);Sodium tetradecyl sulfate (6CI);Alscoap TM 30S;FibroVein;Monotetradecyl sulfate sodium salt;Nikkol SMS;STDS;Sodium myristyl sulfate;Sodium n-tetradecyl sulfate;Sodium tetradecane sulfate;Tetradecyl sodiumsulfate;Texapon K 14;Tromboject; |
Article Data | 5 |
Reported in EPA TSCA Inventory.
Sodium myristyl sulfate(CAS NO.1191-50-0) is also called Sodium tetradecyl sulfate; Sulfuric acid, monotetradecyl ester, sodium salt; 1-Tetradecanol, hydrogen sulfate, sodium salt; 7-Ethyl-2-methyl-4-hendecanol sulfate sodium salt; Monotetradecylsulfate sodium salt ; Myristyl sulfate, sodium salt; NSC 139032; Natri tetradecylsulfas; Niaproof 4; Sodium tetradecyl sulfate; Sodium tetradecyl sulphate; Sodium tetradecylsulfate; Sulfuric acid, monotetradecyl ester, sodium salt; Sulfuric acid, myristyl ester, sodium salt; Tesapon K 14; Tetradecyl sodium sulfate; Tetradecyl sulfate, sodium salt. Sodium myristyl sulfate is white solid. It is stable and incompatible with strong oxidizing agents. Sodium myristyl sulfate is a sclerosant drug. It is commonly used in the treatment of varicose and spider veins of the leg, during the procedure of sclerotherapy.
Physical properties about Sodium myristyl sulfate are: (1)ACD/LogP: 6.457; (2)# of Rule of 5 Violations: 1; (3)ACD/LogD (pH 5.5): 2.96; (4)ACD/LogD (pH 7.4): 2.96; (5)ACD/BCF (pH 5.5): 15.05; (6)ACD/BCF (pH 7.4): 15.05; (7)ACD/KOC (pH 5.5): 24.53 ; (8)ACD/KOC (pH 7.4): 24.53; (9)#H bond acceptors: 4; (10)#H bond donors: 1; (11)#Freely Rotating Bonds: 14
You can still convert the following datas into molecular structure:
(1)InChI=1S/C14H30O4S.Na/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-18-19(15,16)17;/h2-14H2,1H3,(H,15,16,17);/q;+1/p-1;
(2)InChIKey=UPUIQOIQVMNQAP-UHFFFAOYSA-M;
(3)SmilesC(CCCCCCCCCCCC)COS(=O)(=O)[O-].[Na+]
The toxicity data is as follows:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intraperitoneal | 342mg/kg (342mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) VASCULAR: REGIONAL OR GENERAL ARTERIOLAR OR VENOUS DILATION | Journal of the American Pharmaceutical Association, Scientific Edition. Vol. 42, Pg. 283, 1953. |
mouse | LD50 | intravenous | 56mg/kg (56mg/kg) | U.S. Army Armament Research & Development Command, Chemical Systems Laboratory, NIOSH Exchange Chemicals. Vol. NX#00154, |